Evidence map›Paper›PMID 36471321›Full record

ArticleAIDS research and therapy2022

Impact of an intensive facility-community case management intervention on 6-month HIV outcomes among select key and priority populations in Uganda.

David B Meya, Agnes N Kiragga, Elizabeth Nalintya, Grace Banturaki, Joan Akullo, Phillip Kalyesubula, Patrick Sessazi, Hillary Bitakalamire, Joseph Kabanda, Julius N Kalamya and 6 more

Abstract read
In one paragraph

Article in AIDS research and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

David B MeyaInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda. david.meya@gmail.com.
Agnes N KiraggaInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
Elizabeth NalintyaInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
Grace BanturakiInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
Joan AkulloInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
Phillip KalyesubulaInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
Patrick SessaziInfectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
Hillary BitakalamireKalangala District Health Services, Kalangala, Uganda.
Joseph KabandaU.S Centers for Disease Control and Prevention, Kampala, Uganda.
Julius N KalamyaU.S Centers for Disease Control and Prevention, Kampala, Uganda.
Alice NamaleU.S Centers for Disease Control and Prevention, Kampala, Uganda.
Moses BateganyaU.S Centers for Disease Control and Prevention, Atlanta, GA, USA.
Joseph KagaayiRakai Health Sciences, Program, Rakai, Uganda.
Steve GutreuterU.S Centers for Disease Control and Prevention, Atlanta, GA, USA.
Michelle R AdlerU.S Centers for Disease Control and Prevention, Kampala, Uganda.
Kiren MitrukaU.S Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionKey and priority populations (with risk behaviours and health inequities) are disproportionately affected by HIV in Uganda. We evaluated the impact of an intensive case management intervention on HIV treatment outcomes in Kalangala District, predominantly inhabited by fisher folk and female sex workers.

methodsThis quasi-experimental pre-post intervention evaluation included antiretroviral therapy naïve adults aged ≥ 18 years from six health facilities in the pre-intervention (Jan 1, 2017-December 31, 2017) and intervention phase (June 13, 2018-June 30, 2019). The primary outcomes were 6-month retention and viral suppression (VS) before and after implementation of the intervention involving facility and community case managers who supported participants through at least the first three months of ART. We used descriptive statistics to compared the characteristics, overall outcomes (i.e., retention, lost to follow up, died), and VS of participants by phase, and used mixed-effects logistic regression models to determine factors associated with 6-month retention in care. Marginal (averaging over facilities) probabilities of retention were computed from the final multivariable model.

resultsWe enrolled 606 and 405 participants in the pre-intervention and intervention phases respectively. Approximately 75% of participants were aged 25-44 years, with similar age and gender distributions among phases. Approximately 46% of participants in the intervention were fisher folk and 9% were female sex workers. The adjusted probability of 6-month retention was higher in the intervention phase, 0.83 (95% CI: 0.77-0.90) versus pre-intervention phase, 0.73 (95% CI: 0.69-0.77, p = 0.03). The retention probability increased from 0.59 (0.49-0.68) to 0.73 (0.59-0.86), p = 0.03 among participants aged 18-24 years, and from 0.75 (0.71-0.78) to 0.85 (0.78-0.91), p = 0.03 among participants aged ≥ 25 years. VS (< 1,000 copies/mL) was approximately 87% in both phases.

conclusionsAfter implementation of the case management intervention, we observed significant improvement in 6-month retention in all age groups of a highly mobile population of predominantly fisher folk.

Indexed as

Anti-HIV AgentsHIV InfectionsSex WorkersAdultCase ManagementFemaleHealth FacilitiesHumansMaleUgandaAnti-HIV AgentsAntiretroviral therapyHIVKey populationsRetention in careViral suppression

Identifiers

PMID36471321
PMCPMC9724352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.